Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications. It offers Essure, a permanent birth control system for women. The Essure system delivers a micro-insert into a woman's fallopian tubes, causing benign tissue in-growth that blocks the fallopian tubes. The company distributes its products through direct sales force and distributor networks primarily to physicians and hospitals. It primarily operates in the United States, France, and the rest of Europe. Conceptus, Inc. was founded in 1992 and is headquartered in Mountain View, California.